TCIM
PRTK

TIAA CREF Investment Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

TIAA CREF Investment Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$336K Buy
62,711
+670
+1% +$4.33K ﹤0.01% 2744
2018
Q4 		$318K Sell
62,041
-1,181
-2% -$8.97K ﹤0.01% 2752
2018
Q3 		$613K Sell
63,222
-1,290
-2% -$13K ﹤0.01% 2631
2018
Q2 		$658K Sell
64,512
-73,471
-53% -$831K ﹤0.01% 2657
2018
Q1 		$1.79M Buy
137,983
+46,272
+50% +$689K ﹤0.01% 2162
2017
Q4 		$1.64M Buy
91,711
+27,796
+43% +$580K ﹤0.01% 2237
2017
Q3 		$1.6M Sell
63,915
-29,132
-31% -$678K ﹤0.01% 2286
2017
Q2 		$2.24M Buy
93,047
+17,971
+24% +$397K ﹤0.01% 2108
2017
Q1 		$1.45M Buy
75,076
+7,844
+12% +$124K ﹤0.01% 2327
2016
Q4 		$1.03M Buy
67,232
+10,302
+18% +$134K ﹤0.01% 2510
2016
Q3 		$741 Buy
56,930
+8,468
+17% +$112K ﹤0.01% 2689
2016
Q2 		$674K Buy
48,462
+7,804
+19% +$115K ﹤0.01% 2730
2016
Q1 		$617K Hold
40,658
– – ﹤0.01% 2719
2015
Q4 		$771K Sell
40,658
-8,197
-17% -$156K ﹤0.01% 2733
2015
Q3 		$928K Buy
48,855
+8,500
+21% +$212K ﹤0.01% 2607
2015
Q2 		$1.04M Buy
+40,355
New +$1.15M ﹤0.01% 2677
2013
Q3 		– Sell
-267
Closed -$10K – 3115
2013
Q2 		$10K Buy
+267
New +$11.4K ﹤0.01% 3085

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's PRTK Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 1.1% in Q1 2019, buying an estimated $4.33K and bringing the position to 62,711 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2744.

TIAA CREF Investment Management first reported a position in PRTK in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.24M in Q2 2017. 94 funds tracked by Wall St. Rank hold PRTK as of Q1 2019.

  • TIAA CREF Investment Management held 62,711 shares of Paratek Pharmaceuticals, Inc. worth $336K as of Q1 2019.
  • TIAA CREF Investment Management bought 670 Paratek Pharmaceuticals, Inc. shares in Q1 2019, an estimated $4.33K.
  • Paratek Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2744 holding.
  • TIAA CREF Investment Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and has held it in 17 quarters since.
  • TIAA CREF Investment Management's Paratek Pharmaceuticals, Inc. position peaked at $2.24M in Q2 2017.
  • 94 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.